Please Wait.....
Report
Asia Pacific Overactive Bladder Treatment Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Pharmacotherapy (Anticholinergics, Mirabegron, Botox, Neurostimulation, and Intravesical Instillation) and Disease Type (Idiopathic Overactive Bladder and Neurogenic Bladder)
Market Report I 2023-01-23 I 160 Pages I The Insight Partners
The Asia Pacific overactive bladder treatment market is expected to grow from US$ 871.48 million in 2022 to US$ 1,082.25 million by 2028; it is estimated to grow at a CAGR of 3.7% from 2022 to 2028.
Robust Pipeline of Drugs and Successive Launch of Novel Therapies to Bolster Asia Pacific Overactive Bladder Treatment
In December 2020, a new drug application was approved for Gemtesa, a beta 3-agonist and a novel treatment for overactive bladder in adults. Gemtesa (vibegron), provided by Urovant Sciences, helps in relaxing the detrusor bladder muscle, which enables the bladder to hold more urine; the relaxation of this muscle reduces overactive bladder symptoms. It is a once-daily pill and the first overactive bladder medication that does not require dose titration. Many universities and academic institutions are conducting robust research and development activities on novel molecules to treat OAB. For instance, the Yonsei University College of Medicine and Severance Hospital, Seoul, South Korea, is evaluating DA8010, a novel muscarinic M3 receptor antagonist. In September 2021, the university published that in the phase 2 trial, the M3 antagonist DA8010 was demonstrated for the efficacy and safety of overactive bladder treatment. The robust pipeline of drugs for overactive bladder treatment and the successive launch of novel drugs and therapies are expected to drive the growth of the Asia Pacific overactive bladder treatment market in the coming years.
Asia Pacific Overactive Bladder Treatment Market Overview
The Asia Pacific overactive bladder treatment market is segmented into China, Japan, India, South Korea, Australia, South Korea, and the Rest of Asia Pacific. The market growth is attributed to the rising geriatric population, increasing urinary incontinence cases, and a growing number of product launches. Overactive bladder is caused due to abdominal trauma, urinary infection, urinary incontinence, and nerve damage. According to National Centre for Biotechnology (NCBI), in 2019, 1 in 5 individuals above 40 years was identified with symptoms of overactive bladder syndrome in China. The Chinese Medical Journal stated that the rate of overactive bladder cases was 5.9% among people over 18 years in 2019. According to World Health Organization, people aged 60 years in China are expected to grow from 10% in 2021 to 28% by 2041. Further, as per the World Population Aging 2019, in Hong Kong, people aged 60 years and older accounted for 17.5% of the total population in 2019. With the growing geriatric population, the number of patients having an overactive bladder and urinary tract infection is expected to increase in the coming years. All these factors are contributing to the Asia Pacific overactive bladder treatment market growth.
Asia Pacific Overactive Bladder Treatment Market Revenue and Forecast to 2028 (US$ Million)
Asia Pacific Overactive Bladder Treatment Market Segmentation
The Asia Pacific overactive bladder treatment market is segmented on the basis of pharmacotherapy, disease type, and country.
Based on pharmacotherapy, the Asia Pacific overactive bladder treatment market is segmented into anticholinergics, mirabegron, botox, neurostimulation, and intravesical instillation. The mirabegron segment registered the largest share of the Asia Pacific overactive bladder treatment market in 2022.
Based on disease type, the Asia Pacific overactive bladder treatment market is bifurcated into idiopathic overactive bladder and neurogenic bladder. The idiopathic overactive bladder segment held a larger share of the market in 2022.
Based on country, the Asia Pacific overactive bladder treatment market is segmented into China, Japan, India, South Korea, Australia, South Korea, and the Rest of Asia Pacific. China dominated the market in 2022.
AbbVie Inc; Alembic Pharmaceuticals Limited; Astellas Pharma Inc; Endo Pharmaceuticals Inc.; Hisamitsu Pharmaceutical Co., Inc.; Medtronic Plc; Pfizer Inc; and Teva Pharmaceutical Industries Ltd are the leading companies operating in the Asia Pacific overactive bladder treatment market.
TABLE OF CONTENTS
1. Introduction
1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 APAC Overactive Bladder Treatment Market- By Pharmacotherapy
1.3.2 APAC Overactive Bladder Treatment Market- By Disease Type
1.3.3 APAC Overactive Bladder Treatment Market - By Country
2. APAC Overactive Bladder Treatment Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. APAC Overactive Bladder Treatment Market - Market Landscape
4.1 Overview
4.2 APAC PEST Analysis
4.3 Expert Opinion
5. APAC Overactive Bladder Treatment Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Increase in Prevalence of Urinary Incontinence
5.1.2 Growing Incidence of Urinary Tract Infections
5.2 Key Market Restraints
5.2.1 Recalls of Therapeutic Drugs
5.3 Key Market Opportunities
5.3.1 Increasing Number of Mergers and Acquisitions
5.4 Future Trends
5.4.1 Robust Pipeline of Drugs and Successive Launch of Novel Therapies
5.5 Impact analysis
6. Overactive Bladder Treatment Market - APAC Analysis
6.1 APAC Overactive Bladder Treatment Market Revenue Forecast and Analysis
7. APAC Overactive Bladder Treatment Market Analysis and Forecasts To 2028 - By Pharmacotherapy
7.1 Overview
7.2 APAC Overactive Bladder Treatment Market, By Pharmacotherapy 2021 & 2028 (%)
7.3 Mirabegron
7.3.1 Overview
7.3.2 Mirabegron: APAC Overactive Bladder Market Revenue and Forecast to 2028 (US$ Million)
7.4 Botox
7.4.1 Overview
7.4.2 Botox: APAC Overactive Bladder Market Revenue and Forecast to 2028 (US$ Million)
7.5 Neurostimulation
7.5.1 Overview
7.5.2 Neurostimulation: APAC Overactive Bladder Market Revenue and Forecast to 2028 (US$ Mn)
7.5.3 Transcutaneous Sacral Nerve Stimulation
7.5.3.1 Overview
7.5.3.2 Transcutaneous Sacral Nerve Stimulation: APAC Overactive Bladder Market Revenue and Forecast to 2028 (US$ Mn)
7.5.4 Transcutaneous Tibial Nerve Stimulation
7.5.4.1 Overview
7.5.4.2 Transcutaneous Tibial Nerve Stimulation: APAC Overactive Bladder Market Revenue and Forecast to 2028 (US$ Mn)
7.5.5 Percutaneous Posterior Tibial Nerve Stimulation
7.5.5.1 Overview
7.5.5.2 Percutaneous Posterior Tibial Nerve Stimulation: APAC Overactive Bladder Market Revenue and Forecast to 2028 (US$ Mn)
7.5.6 Others
7.5.6.1 Overview
7.5.6.2 Others: APAC Overactive Bladder Market Revenue and Forecast to 2028 (US$ Mn)
7.6 Anticholinergics
7.6.1 Overview
7.6.2 Anticholinergics: APAC Overactive Bladder Market Revenue and Forecast to 2028 (US$ Million)
7.6.3 Solifenacin
7.6.3.1 Overview
7.6.3.2 Solifenacin: APAC Overactive Bladder Market Revenue and Forecast to 2028 (US$ Million)
7.6.4 Oxybutynin
7.6.4.1 Overview
7.6.4.2 Oxybutynin: APAC Overactive Bladder Market Revenue and Forecast to 2028 (US$ Million)
7.6.5 Fesoterodine
7.6.5.1 Overview
7.6.5.2 Fesoterodine: APAC Overactive Bladder Market Revenue and Forecast to 2028 (US$ Million)
7.6.6 Darifenacin
7.6.6.1 Overview
7.6.6.2 Darifenacin: APAC Overactive Bladder Market Revenue and Forecast to 2028 (US$ Million)
7.6.7 Tolterodine
7.6.7.1 Overview
7.6.7.2 Tolterodine: APAC Overactive Bladder Market Revenue and Forecast to 2028 (US$ Million)
7.6.8 Trospium
7.6.8.1 Overview
7.6.8.2 Trospium: APAC Overactive Bladder Market Revenue and Forecast to 2028 (US$ Million)
7.6.9 Other Anticholinergics
7.6.9.1 Overview
7.6.9.2 Other Anticholinergics: APAC Overactive Bladder Market Revenue and Forecast to 2028 (US$ Million)
7.7 Intravesical Instillation
7.7.1 Overview
7.7.2 Intravesical Instillation: APAC Overactive Bladder Market Revenue and Forecast to 2028 (US$ Mn)
8. APAC Overactive Bladder Treatment Market Analysis and Forecasts To 2028 - By Disease Type
8.1 Overview
8.2 APAC Overactive Bladder Treatment Market, By Disease Type 2021 & 2028 (%)
8.3 Idiopathic Overactive Bladder
8.3.1 Overview
8.3.2 Idiopathic: Overactive Bladder Market Revenue and Forecast to 2028 (US$ Mn)
8.4 Neurogenic Overactive Bladder
8.4.1 Overview
8.4.2 Neurogenic: Overactive Bladder Market Revenue and Forecast to 2028 (US$ Mn)
9. Overactive Bladder Treatment Market Revenue and Forecasts to 2028 - Country Analysis
9.1 Overview
9.1.1 APAC: Overactive Bladder Treatment Market, by Country, 2021 & 2028 (%)
9.1.1.1 China: overactive bladder treatment Market - Revenue and Forecast to 2028 (USD Million)
9.1.1.1.1 China: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
9.1.1.1.2 China: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019-2028 (US$ Million)
9.1.1.1.2.1 China: Overactive Bladder Treatment Market, by Anticholinergic, 2019-2028 (US$ Million)
9.1.1.1.2.2 China Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (USD Million)
9.1.1.1.3 China: Overactive Bladder Treatment Market, by Disease Type, 2019-2028 (US$ Million)
9.1.1.2 Japan: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
9.1.1.2.1 Japan: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
9.1.1.2.2 Japan: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019-2028 (US$ Million)
9.1.1.2.2.1 Japan: Overactive Bladder Treatment Market, by Anticholinergic, 2019-2028 (US$ Million)
9.1.1.2.2.2 Japan Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (USD Million)
9.1.1.2.3 Japan: Overactive Bladder Treatment Market, by Disease Type, 2019-2028 (US$ Million)
9.1.1.3 India: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (USD Million)
9.1.1.3.1 India: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
9.1.1.3.2 India: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019-2028 (US$ Million)
9.1.1.3.2.1 India: Overactive Bladder Treatment Market, by Anticholinergic, 2019-2028 (US$ Million)
9.1.1.3.2.2 India Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (USD Million)
9.1.1.3.3 India: Overactive Bladder Treatment Market, by Disease Type, 2019-2028 (US$ Million)
9.1.1.4 South Korea: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
9.1.1.4.1 South Korea: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
9.1.1.4.2 South Korea: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019-2028 (US$ Million)
9.1.1.4.2.1 South Korea: Overactive Bladder Treatment Market, by Anticholinergic, 2019-2028 (US$ Million)
9.1.1.4.2.2 South Korea Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (USD Million)
9.1.1.4.3 South Korea: Overactive Bladder Treatment Market, by Disease Type, 2019-2028 (US$ Million)
9.1.1.5 Australia: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
9.1.1.5.1 Australia: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
9.1.1.5.2 Australia: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019-2028 (US$ Million)
9.1.1.5.2.1 Australia: Overactive Bladder Treatment Market, by Anticholinergic, 2019-2028 (US$ Million)
9.1.1.5.2.2 Australia Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (USD Million)
9.1.1.5.3 Australia: Overactive Bladder Treatment Market, by Disease Type, 2019-2028 (US$ Million)
9.1.1.6 Rest of APAC: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
9.1.1.6.1 Rest of APAC: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
9.1.1.6.2 Rest of APAC: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019-2028 (US$ Million)
9.1.1.6.2.1 Rest of APAC: Overactive Bladder Treatment Market, by Anticholinergic, 2019-2028 (US$ Million)
9.1.1.6.2.2 Rest of APAC Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (USD Million)
9.1.1.6.3 Rest of APAC: Overactive Bladder Treatment Market, by Disease Type, 2019-2028 (US$ Million)
10. Overactive Bladder Treatment Market- Industry Landscape
10.1 Overview
10.2 Organic Developments
10.2.1 Overview
11. Company Profiles
11.1 Alembic Pharmaceuticals Limited
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Astellas Pharma Inc
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 AbbVie Inc
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Teva Pharmaceutical Industries Ltd
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Endo Pharmaceuticals Inc.
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Hisamitsu Pharmaceutical Co. Inc.
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Medtronic Plc
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 Pfizer Inc
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments
12. Appendix
12.1 About The Insight Partners
12.2 Glossary of Terms
LIST OF TABLES
Table 1. China Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
Table 2. China Overactive Bladder Treatment Market, by Anticholinergic - Revenue and Forecast to 2028 (US$ Million)
Table 3. China Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
Table 4. China Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
Table 5. Japan Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
Table 6. Japan Overactive Bladder Treatment Market, by Anticholinergic - Revenue and Forecast to 2028 (US$ Million)
Table 7. Japan Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
Table 8. Japan Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
Table 9. India Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
Table 10. India Overactive Bladder Treatment Market, by Anticholinergic - Revenue and Forecast to 2028 (US$ Million)
Table 11. India Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
Table 12. India Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
Table 13. South Korea Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
Table 14. South Korea Overactive Bladder Treatment Market, by Anticholinergic - Revenue and Forecast to 2028 (US$ Million)
Table 15. South Korea Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
Table 16. South Korea Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
Table 17. Australia Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
Table 18. Australia Overactive Bladder Treatment Market, by Anticholinergic - Revenue and Forecast to 2028 (US$ Million)
Table 19. Australia Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
Table 20. Australia Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
Table 21. Rest of APAC Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
Table 22. Rest of APAC Overactive Bladder Treatment Market, by Anticholinergic - Revenue and Forecast to 2028 (US$ Million)
Table 23. Rest of APAC Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
Table 24. Rest of APAC Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
Table 25. Organic Developments Done by Companies
Table 26. Glossary of Terms
LIST OF FIGURES
Figure 1. APAC Overactive Bladder Treatment Market Segmentation
Figure 2. APAC Overactive Bladder Treatment Market Segmentation, By Country
Figure 3. APAC Overactive Bladder Treatment Market Overview
Figure 4. Mirabegron Segment Held Largest Share by Pharmacotherapy in APAC Overactive Bladder Treatment market
Figure 5. Asia-Pacific Region Is Expected to Show Remarkable Growth During the Forecast Period
Figure 7. APAC: PEST Analysis
Figure 8. APAC Overactive Bladder Treatment Market: Impact Analysis of Driver and Restraints
Figure 9. APAC Overactive Bladder Treatment Market - Revenue Forecast and Analysis - 2020- 2028
Figure 10. APAC Overactive Bladder Treatment Market, by Pharmacotherapy 2021 & 2028 (%)
Figure 11. Mirabegron: APAC Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Million)
Figure 12. Botox: APAC Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Million)
Figure 13. Neurostimulation: APAC Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 14. Transcutaneous Sacral Nerve Stimulation: APAC Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 15. Transcutaneous Tibial Nerve Stimulation: APAC Overactive Bladder Market Revenue and Forecasts to 2028 (US$ MN)
Figure 16. Percutaneous Posterior Tibial Nerve: APAC Overactive Bladder Stimulation Market Revenue and Forecasts To 2028 (US$ MN)
Figure 17. Others: APAC Overactive Bladder Market Revenue and Forecasts To 2028 (US$ MN)
Figure 18. Anticholinergics: APAC Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Million)
Figure 19. Solifenacin: APAC Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Million)
Figure 20. Oxybutynin: APAC Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Million)
Figure 21. Fesoterodine: APAC Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Million)
Figure 22. Darifenacin: APAC Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Million)
Figure 23. Tolterodine: APAC Overactive Bladder Market Revenue and Forecasts To 2028 (US$ Million)
Figure 24. Trospium: APAC Overactive Bladder Market Revenue and Forecasts To 2028 (US$ Million)
Figure 25. Other Anticholinergics: APAC Overactive Bladder Market Revenue and Forecasts To 2028 (US$ Million)
Figure 26. Intravesical Instillation: APAC Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 27. APAC Overactive Bladder Treatment Market, by Disease Type 2021 & 2028 (%)
Figure 28. Idiopathic: Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 29. Neurogenic: Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 30. APAC: Overactive Bladder Treatment Market, by Key Country - Revenue (2021) (US$ Million)
Figure 31. China: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
Figure 32. Japan: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
Figure 33. India: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
Figure 34. South Korea: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
Figure 35. Australia: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
Figure 36. Rest of APAC: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security